Bio/Pharma Business

Sandoz and Just – Evotec Biologics Form Biosimilars Pact

May 12, 2023

The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.

Baxter Divests BioPharma Solutions Department in $4.25 Billion Deal

May 10, 2023

Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.

Ginkgo Bioworks and Boehringer Ingelheim Sign $405 Million Drug Discovery Deal

May 09, 2023

Boehringer Ingelheim will use Ginkgo’s metagenomic sequence database to identify potential lead molecules for diseases with high unmet patient needs.

Ramping Up Nucleic Acid Therapy Development

May 03, 2023

The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.

Young Pups and Leopards

May 02, 2023

The engine that drives pharmaceuticals forward, its workforce, is now very low on fuel.

Aspect Biosystems, Novo Nordisk Partner to Develop Bioprinted Tissue Therapeutics

April 25, 2023

Aspect Biosystems and Novo Nordisk A/S have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics.

EHA Data Leak Shows Positive J&J Cancer Treatment Findings

April 25, 2023

The leaked study summary found that Carvykti (ciltacabtagene autoleucel) reduced disease progression by 74%.

Indian Pharma Companies Poised for Surge?

April 21, 2023

A report from Business Standard highlighted India’s recent growth in the pharma sector.

GSK and BELLUS Health Enter Acquisition Agreement

April 20, 2023

GSK has reached an agreement to acquire late-stage biopharmaceutical company BELLUS Health.

Merck to Purchase Prometheus Biosciences for $10.8 Billion

April 18, 2023

Merck will acquire Prometheus Biosciences, a clinical-stage biotechnology company specializing in immune-mediated diseases, at a total equity valuation of $10.8 billion.